Literature DB >> 7235415

Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.

J H Hoofnagle, G M Dusheiko, L B Seeff, E A Jones, J G Waggoner, Z B Bales.   

Abstract

Twenty-five patients with chronic type B hepatitis documented by liver biopsy were followed for 1 to 6 years with serial measurements of aminotransferase levels, hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and antibody (anti-HBe), and hepatitis B virus DNA polymerase. Initially, all were positive for HBsAg and HBeAg and had elevations in serum aminotransferases. In follow-up, only one lost HBsAg reactivity. In 13, however, elevated aminotransferase levels spontaneously fell to normal and have remained normal. These 13 also had a seroconversion from HBeAg to anti-HBe, and all became negative for serum DNA polymerase. Most had a fall in HBsAg titer. This seroconversion occurred concurrently with or several months before the fall in aminotransferase levels. In contrast, the 12 persons who remained HBeAg positive continued to have elevated aminotransferase levels. All 10 of these patients who were initially positive for DNA polymerase remained positive. These data suggest that many patients with chronic type B hepatitis eventually have a spontaneous remission in clinical and biochemical evidence of active disease, usually heralded or accompanied by the disappearance of HBeAg and DNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7235415     DOI: 10.7326/0003-4819-94-6-744

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  86 in total

1.  Early mutation of precore (A1896) region prior to core promoter region mutation leads to decrease of HBV replication and remission of hepatic inflammation.

Authors:  Y Karino; J Toyota; T Sato; T Ohmura; K Yamazaki; T Suga; K Nakamura; M Sugawara; T Matsushima; K Hino
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

3.  Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis B.

Authors:  S V Feinman; B Berris; R Sooknanan; B Fernandes; S Bojarski
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

4.  Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.

Authors:  T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda
Journal:  Gastroenterol Jpn       Date:  1990-02

5.  The dynamics of hepatitis B virus infection.

Authors:  R J Payne; M A Nowak; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Investigation of HBV infection status in anti-HBe Chinese patients with chronic hepatitis by in situ hybridization assay.

Authors:  Y Y Zhang; Y K Wang; L J Hao; Y C Zhu
Journal:  J Tongji Med Univ       Date:  1989

7.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

8.  Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection.

Authors:  Kazumoto Murata; Kazushi Sugimoto; Katsuya Shiraki; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

9.  Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene.

Authors:  E Schulte-Frohlinde; G R Foster
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.